IPSC
Century Therapeutics Inc
1.50$
-3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 15,397.3% | 8,319.4% | 377.3% | 449.0% | 416.8% | 79.5% | – | – | – | – | – | – | – | |
| -15,297.3% | -8,219.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 18,100.0% | 8,692.5% | 2,739.3% | 3,530.5% | 3,442.2% | 703.9% | 24.3% | – | – | – | – | – | – | |
| 6,071.6% | 3,204.9% | 1,022.6% | 1,077.3% | 1,055.9% | 185.8% | 7.7% | – | – | – | – | – | – | |
| 8,774.3% | 8,109.7% | 3,761.9% | 4,607.8% | 4,498.1% | 993.5% | 32.1% | – | – | – | – | – | – | |
| -24,071.6% | -16,329.1% | -3,661.9% | -4,507.8% | -4,398.1% | -893.5% | 67.9% | – | – | – | – | – | – | |
| 0.0% | 403.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -21,708.1% | -15,025.0% | -3,282.0% | -4,044.7% | -3,948.7% | -821.9% | 70.1% | – | – | – | – | – | – | |
| 400.0% | -324.3% | 0.1% | 2.9% | -1.0% | 42.6% | – | – | – | – | – | – | – | |
| -22,108.1% | -14,700.7% | -3,282.1% | -4,047.6% | -3,947.7% | -864.4% | 70.1% | – | – | – | – | – | – | |
| -19,105.4% | -10,098.9% | -2,904.7% | -3,595.7% | -3,531.7% | -742.4% | 73.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.